SCHEMBL534191

SCHEMBL534191

Cc1cc(C)c(N2CCCC2)c(C)c1NC(=O)c1cccc(N)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
KDM4E B2RXH2 1/20 0.50
CNR1 P21554 1/20 0.43
GFER P55789 1/20 0.42
SMN1; SMN2 Q16637 6/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MEN1 O00255 2/20 0.42
MAPK1 P28482 2/20 0.42
KMT2A Q03164 2/20 0.42
GAA P10253 1/20 0.42
KDM4C Q9H3R0 1/20 0.41
TSHR P16473 2/20 0.41
NPC1 O15118 5/20 0.41
RAB9A P51151 4/20 0.41
MAPT P10636 4/20 0.41
LMNA P02545 3/20 0.41
QSOX1 O00391 1/20 0.41
PKM P14618 1/20 0.41
TP53 P04637 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL532941 0.88 MAPT (0.51) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL533054 0.88 MAPT (0.45) ALDH1A1KDM4EGFERSMN1; SMN2MEN1
SCHEMBL533966 0.87 POLB (0.44) ALDH1A1KDM4ESMN1; SMN2NPSR1MEN1
SCHEMBL532849 0.87 SMN1; SMN2 (0.49) ALDH1A1KDM4ESMN1; SMN2HSD17B10MEN1
SCHEMBL533539 0.86 RAB9A (0.47) ALDH1A1SMN1; SMN2MEN1KMT2AGAA
SCHEMBL532034 0.86 NPC1 (0.57) ALDH1A1KDM4ECNR1MEN1KMT2A
SCHEMBL534049 0.85 SCN9A (0.47) ALDH1A1KDM4EGFERSMN1; SMN2MEN1
SCHEMBL532995 0.82 NPC1 (0.54) ALDH1A1KDM4ECNR1SMN1; SMN2MEN1
SCHEMBL532967 0.81 RAB9A (0.57) ALDH1A1KDM4ESMN1; SMN2NPSR1MEN1
SCHEMBL532794 0.81 POLB (0.45) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
WO-2004073634-A2 PHENYLENEDIAMINE UROTENSIN-II RECEPTOR ANTAGONISTS AND CCR-9 ANTAGONISTS ENCYSIVE PHARMACEUTICALS INC. (US) 2004-09-02 WO disclosed